Related Experiment Video
Updated: Jul 10, 2025

Biological Compatibility Profile on Biomaterials for Bone Regeneration
Published on: November 16, 2018
Recombinant Human Parathyroid Hormone Biocomposite Promotes Bone-to-Tendon Interface Healing by Enhancing
Jian Han1, Sheng Chen Han2, Hyeon Jang Jeong2
1Department of Orthopaedic Surgery, The First People's Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China.
Recombinant human parathyroid hormone (rhPTH) biocomposite significantly enhanced bone-to-tendon interface healing in a rabbit rotator cuff tear model. This biomaterial promoted tenogenesis, chondrogenesis, and osteogenesis for improved surgical repair outcomes.
Area of Science:
- Biomaterials science
- Orthopedic surgery
- Regenerative medicine
Background:
- Chronic rotator cuff tears (RCTs) present a significant challenge in orthopedic surgery.
- Effective healing of the bone-to-tendon interface (BTI) is crucial for successful RCT repair.
- Current treatments often yield suboptimal functional recovery, necessitating innovative therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy of a novel recombinant human parathyroid hormone (rhPTH) biocomposite in promoting BTI healing.
- To assess the impact of the rhPTH biocomposite on genetic, histologic, biomechanical, and micro-CT parameters in a rabbit chronic RCT model.
Main Methods:
- Sixty-four rabbits with chronic RCTs were divided into four groups: saline, nanofiber sheet alone, rhPTH-soaked nanofiber sheet, and rhPTH biocomposite.
- rhPTH release kinetics were analyzed in vitro.
- Nanofiber scaffolds were implanted post-surgery, with evaluations at 4 and 12 weeks.
- Analyses included gene expression (COL1A1, COL3A1, BMP-2), histology, biomechanics, micro-CT, and serology.
Main Results:
- The rhPTH biocomposite group demonstrated significantly higher mRNA expression of COL1A1, COL3A1, and BMP-2 at 4 weeks post-surgery.
- At 12 weeks, the rhPTH biocomposite group exhibited superior collagen fiber continuity, orientation, density, mature fibrocartilage, and bone-to-tendon junction formation.
- Biomechanical testing revealed the highest load-to-failure rate in the rhPTH biocomposite group (48.2 ± 4.5 N/kg).
- Micro-CT analysis confirmed enhanced bone and tissue mineral density and bone volume in the rhPTH biocomposite group.
Conclusions:
- rhPTH biocomposite effectively accelerates BTI healing in a chronic RCT rabbit model.
- The biocomposite enhances early gene expression and promotes tenogenesis, chondrogenesis, and osteogenesis by 12 weeks.
- This study suggests rhPTH biocomposites are a promising adaptable biomaterial for human RCT repair.
More Related Videos
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...